01440 782 100(Monday - Friday 8.30am - 5pm)
Loading Events

« All Events

  • This event has passed.

OBN BioTuesday: Life Sciences Spotlight – AI and Data Innovation in the East of England

March 15, 2022 @ 18:00 - 21:30

Companies showcasing at the event are using AI and machine learning to both diagnose and treat the causes of cancer and other diseases, as well as using data anaylsis to optimise the drug discovery process.

The evening will commence with a scene setting update from Dr Namshik Han​, Head of Computational Research & Artificial Intelligence, Milner Therapeutics Institute, who will share their insight on the latest innovation in this space, with a particular focus on the East of England Region, followed by 6 x 10-minute company showcase presentations.

All presenters will join for an audience Q&A at the end of the session before a networking drinks reception, which is kindly provided by event host, the Epicentre.

Event Format:

17.30 – 18.00 Delegate Registration

18.00  18.10 Welcome and Introductions by OBN and the team at the Epicentre

18.10  18.30 Keynote/Industry Update from Dr Namshik Han​, Head of Computational Research & Artificial Intelligence, Milner Therapeutics Institute

18.30 – 19.30 Company showcase presentations from:

1) Bipin Patel, Founder & CEO of ElectronRX​

2) Carlos Luzzani, Co-Founder & CSO of MultiplAI Health​

3) Matthew Segal, CEO of Optibrium​

4) Davide Pennino, Founder of Biotix​

5) Debora Lucarelli, CEO of Enhanc3D Genomics​

19.30 – 19.40 Audience Q&A

About our hosts The Epicentre

 

The fundamental objectives of the Epicentre is to create a space that attracts ambitious, growing technology and life science led SMEs, start-ups and growing businesses to create a vibrant community of innovators and a place in which business can thrive.

  • Delivering flexible work, meeting & event space for start-up/scale-up companies
  • Supporting community development and creating a collaborative ‘Community Space’ as an attractive destination for business providing opportunities to meet and collaborate with like-minded innovators
  • Expert advice and support to help tenants develop and grow their businesses including additional specialist innovation development support tailored to meet the needs of users

This BioTuesday event is kindly co-marketed with One Nucleus

Terms and Conditions of OBN Events

Organiser

Venue

The EpiCentre, Haverhill
Enterprise Way, Haverhill Research Park
Haverhill, Cambridgeshire CB9 7LR United Kingdom
+ Google Map
Phone
01440 782100
View Venue Website

Book a Tour

Join an inspiring community of innovators and entrepreneurs.

  • Book a tour of The EpiCentre
  • Get more information on workspace sizes, pricing & availability
  • Have your questions answered
  • Secure your choice of office, lab, coworking or meeting space

01440 782 100
(Monday – Friday 8.30am – 5pm)

info@epicentrehaverhill.co.uk

Name
This field is for validation purposes and should be left unchanged.

Get in Touch

Join an inspiring and ambitious community. 

  • Get more information on workspace sizes, pricing & availability
  • Have your questions answered
  • Secure your choice of office, lab, coworking or meeting space

01440 782 100
(Monday – Friday 8.30am – 5pm)

info@epicentrehaverhill.co.uk

I'm interested in...
Name(Required)
This field is for validation purposes and should be left unchanged.

Ready to sign up for Lab space?

Space to experiment, space to research

  • Get more information on pricing & availability
  • Arrange a viewing of The EpiCentre lab space
  • Have your questions answered
  • Reserve your lab space

01440 782 100
(Monday – Friday 8.30am – 5pm)

info@epicentrehaverhill.co.uk

Name
This field is for validation purposes and should be left unchanged.

Covid-19 Statement

Update – 11 August 2022

Our Innovation Centres remain operational and accessible, and provide a safe environment for our staff and customers. We continue to assess the risk of COVID-19 alongside the latest guidance from government. In the meantime our Innovation Centre remains COVID-19 Secure and fully open for business. Our detailed risk assessment can be found here.